Kyoto University

organization

Last mentioned: Mar 6, 2026

Timeline

  1. Regulatory Approval

    Japan grants official approval for commercial use of the therapy.

  2. Trial Completion

    Phase II data confirms safety and efficacy in human subjects.

  3. First Human Trial

    Kyoto University begins the world's first iPS cell transplant for Parkinson's.

  4. Nobel Prize

    Yamanaka wins the Nobel Prize in Medicine for his iPS cell research.

  5. iPS Discovery

    Shinya Yamanaka discovers how to create induced pluripotent stem cells.

Stories mentioning Kyoto University 1

fda-approval Very Bullish

Japan Grants World-First Approval for iPS Stem-Cell Parkinson's Therapy

Japan has officially approved the world's first stem-cell-based treatment for Parkinson's disease, utilizing induced pluripotent stem (iPS) cells. The therapy, developed by Kyoto University and Sumitomo Pharma, marks a historic shift from symptom management to regenerative repair for neurodegenerative disorders.

3 sources